Very poor performance status elderly patients with aggressive B cell lymphomas can benefit from intensive chemotherapy

British Journal of Haematology

Volumn 157, Issue 3, 2012, Pages 391-393

  Bowcock, Stella J ^a   Fontana, Vincenzo ^a   Patrick, Hannah E ^a  

^a South London Healthcare National Health Service Trust   (United Kingdom)

Author keywords

Chemotherapy; Elderly; Frail; Lymphoma; Moribund; Poor performance status

Indexed keywords

BLEOMYCIN; CYCLOPHOSPHAMIDE; CYTARABINE; DEXAMETHASONE; DOXORUBICIN; ETOPOSIDE; IDARUBICIN; IFOSFAMIDE; LOMUSTINE; METHOTREXATE; MITOXANTRONE; PREDNISOLONE; RITUXIMAB; VINCRISTINE;

AGED; BURKITT LYMPHOMA; CLINICAL ARTICLE; COMORBIDITY; DRUG TOLERABILITY; ELDERLY CARE; HEART ATRIUM FIBRILLATION; HOSPITAL READMISSION; HUMAN; INTERNATIONAL PROGNOSTIC SCORING SYSTEM; LARGE CELL LYMPHOMA; LENGTH OF STAY; LETTER; MULTIPLE CYCLE TREATMENT; OVERALL SURVIVAL; PATIENT SELECTION; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; TREATMENT OUTCOME; UNSPECIFIED SIDE EFFECT;

AGE FACTORS; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; HUMANS; LYMPHOMA, B-CELL; PROGNOSIS; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 84859510129     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2011.08987.x     Document Type: Letter

References (10)

1. Cullen, M., Steven, N., Billingham, L., Gaunt, C., Hastings, M., Simmonds, P., Stuart, N., Rea, D., Bower, M., Fernando, I., Huddart, R., Gollins, S. & Stanley, A. (2005) Antibacterial prophylaxis after chemotherapy for solid tumors and lymphomas. The New England Journal of Medicine, 353, 988-998.
2. Lichtman, S.M. (2006) Therapy insight: therapeutic challenges in the treatment of elderly cancer patients. Nature Clinical Practice. Oncology, 3, 86-93.
3. Peters, F.P., Fickers, M.M., Erdkamp, F.L., Wals, J., Wils, J.A. & Schouten, H.C. (2001) The effect of optimal treatment on elderly patients with aggressive non-Hodgkin's lymphoma: more patients treated with unaffected response rates. Annals of Hematology, 80, 406-410.
4. Pfreundschuh, M. (2010) How I treat elderly patients with diffuse large B-cell lymphoma. Blood, 116, 5103-5110.
5. Pfreundschuh, M., Schubert, J., Ziepert, M., Schmits, R., Mohren, M., Lengfelder, E., Reiser, M., Nickenig, C., Clemens, M., Peter, N., Bokemeyer, C., Eimermacher, H., Ho, A., Hoffmann, M., Mertelsmann, R., Trumper, L., Balleisen, L., Liersch, R., Metzner, B., Hartmann, F., Glass, B., Poeschel, V., Schmitz, N., Ruebe, C., Feller, A.C. & Loeffler, M. (2008) Six versus eight cycles of bi-weekly CHOP-14 with or without rituximab in elderly patients with aggressive CD20+ B-cell lymphomas: a randomised controlled trial (RICOVER-60). The Lancet Oncology, 9, 105-116.
6. Shipp, M. (1993) A predictive model for aggressive lymphoma: the International NHL Prognostic Factors Project. New England Journal of Medicine, 329, 987-994.
7. Slevin, M.L., Stubbs, L., Plant, H.J., Wilson, P., Gregory, W.M., Armes, P.J. & Downer, S.M. (1990) Attitudes to chemotherapy: comparing views of patients with cancer with those of doctors, nurses, and general public. BMJ, 300, 1458-1460.
8. Thieblemont, C. & Coiffier, B. (2007) Lymphoma in older patients. Journal of Clinical Oncology, 25, 1916-1923.
9. Thieblemont, C., Grossoeuvre, A., Houot, R., Broussais-Guillaumont, F., Salles, G., Traulle, C., Espinouse, D. & Coiffier, B. (2008) Non-Hodgkin's lymphoma in very elderly patients over 80years. A descriptive analysis of clinical presentation and outcome. Annals of Oncology, 19, 774-779.
10. Tirelli, U., Carbone, A., Monfardini, S. & Zagonel, V. (2001) A 20-year experience on malignant lymphomas in patients aged 70 and older at a single institute. Critical Reviews in Oncology/Hematology, 37, 153-158.